EichorEICHOR
Study identifier: NCT00967863 Synced from ClinicalTrials.gov · August 02, 2026
● Active Not Recruiting

Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)

Condition: Prostate Cancer  ·  Sponsor: UNICANCER

PhaseNA
Planned participants500
Who can joinMale, 18 Years to 80 Years
Healthy volunteersNo

About this study

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. It is not yet known which dose of radiation therapy is more effective in treating patients with prostate cancer. PURPOSE: This randomized phase III trial is comparing two radiation therapy regimens in treating patients with prostate cancer receiving hormone therapy.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (25)

Institut de Cancérologie de l'Ouest Paul PapinAngers, France
Institut BergonieBordeaux, France
Centre Francois BaclesseCaen, France
Centre hospitalier Métropole SavoieChambéry, France
Clinique Léonard de VinciChambray-lès-Tours, France
CHU Henri MondorCréteil, France
Centre Léon BérardLyon, France
Hopital La TimoneMarseille, France
Centre de Cancérologie du Grand MontpellierMontpellier, France
Centre Val D'AurelleMontpellier, France
Centre Azureen de CancerologieMougins, France
Chr OrleansOrléans, France

+ 13 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →